Warfarin is recognized as the standard antithrombotic agent for stroke prevention. However. new oral anticoagulant such as dabigatran constitutes huge improvement to compensate for the limitation of warfarin. A literature review was performed to compare and contrast the overall benefit of dabigatran and warfarin among patients with atrial fibrillation. https://www.diegojavierfares.com/special-offer-Rothbury-Chrome-two-handle-low-arc-bathroom-faucet-p13193-best-find/